» Articles » PMID: 7044980

Chlamydia Trachomatis: Serological Diagnosis

Overview
Journal Infection
Date 1982 Jan 1
PMID 7044980
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Satisfactory methods for the serodiagnosis of Chlamydia trachomatis have been widely discussed in recent years. Until a decade ago, the complement-fixation test measuring group-specific antibody was the most widely applied technique. However, despite showing relatively high diagnostic sensitivity in systemic chlamydial infections, it is of little value in the serodiagnosis of localized chlamydial oculo-genital infections or of trachoma. The more recently developed microimmunofluorescence (micro-IF) test is not only a very sensitive technique, but can also reach a high degree of serodiagnostic specificity in certain chlamydial infections. Unlike the complement-fixation test, it measures type-specific antibody which may be directed against one or more C trachomatis serotypes. By nature, chlamydia infections often lead to high background rates of antibody in affected populations. Interpretation of serological results may therefore be difficult, particularly when only single-serum samples are available. However, in seroepidemiological work, in the study of transmission patterns and in the detection of predominant serotypes in a community, the micro-IF test is especially valuable, and if results are interpreted with care, the test may also serve as an indicator of chlamydial infection. The predictability, sensitivity and specificity of serological tests for C. trachomatis will be discussed.

Citing Articles

Chlamydial eye infections: Current perspectives.

Satpathy G, Behera H, Ahmed N Indian J Ophthalmol. 2017; 65(2):97-102.

PMID: 28345563 PMC: 5381307. DOI: 10.4103/ijo.IJO_870_16.


High frequency of latent Chlamydia trachomatis infection in patients with rhegmatogenous retinal detachment.

Boiko E, Pozniak A, Maltsev D, Suetov A, Nuralova I Int J Ophthalmol. 2016; 9(6):863-8.

PMID: 27366689 PMC: 4916144. DOI: 10.18240/ijo.2016.06.13.


The incidence of Chlamydia psittaci antibodies in patients with respiratory tract diseases.

von Graevenitz A, LENNETTE E Infection. 1982; 10(4):240.

PMID: 7129645 DOI: 10.1007/BF01666918.

References
1.
Mardh P, URSING B, Sandgren E . Lack of evidence for an association between infection with Chlamydia trachomatis and Crohn's disease, as indicated by micro-immunofluorescence antibody tests. Acta Pathol Microbiol Scand B. 1980; 88(1):57-9. DOI: 10.1111/j.1699-0463.1980.tb02604.x. View

2.
Ng K, Graham D, Forsyth J, Brennan K . Antichlamydial antibody in genital exudates of men and women with non-gonococcal genital infections. Lancet. 1978; 1(8062):507. DOI: 10.1016/s0140-6736(78)90177-0. View

3.
Thomas B, Reeve P, Oriel J . Simplified serological test for antibodies to Chlamydia trachomatis. J Clin Microbiol. 1976; 4(1):6-10. PMC: 274379. DOI: 10.1128/jcm.4.1.6-10.1976. View

4.
Terho P, Meurman O . Chlamydial serum IgG, IgA and local IgA antibodies in patients with genital-tract infections measured by solid-phase radioimmunoassay. J Med Microbiol. 1981; 14(1):77-87. DOI: 10.1099/00222615-14-1-77. View

5.
Swarbrick E, Kingham J, Price H, Blackshaw A, Griffiths P, Darougar S . Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease. Lancet. 1979; 2(8132):11-2. DOI: 10.1016/s0140-6736(79)90176-4. View